STOCK TITAN

Tilray Brands Marks Seven Years of Cannabis Legalization in Canada with the #1 Market-Leading Position by Revenue and Pioneering Brands with Growing Market Share in the World’s Largest Federally Legal Cannabis Market

Rhea-AI Impact
(Moderate)
Rhea-AI Sentiment
(Positive)
Tags

Tilray Brands (Nasdaq: TLRY) marked seven years since Canada legalized cannabis, reiterating its position as Canada's largest legal cannabis company by revenue and highlighting market-leading brands and product categories. The company cites >C$1 billion invested in Canadian infrastructure, ~C$700 million paid in excise taxes, ownership of 15 leading brands (several retail-valued C$100M–C$300M), and Q1FY26 operational strength.

Tilray reports 5 million sq ft cultivation capacity, current production of 210 metric tons, and >40% beverage market share for XMG/Mollo.

Tilray Brands (Nasdaq: TLRY) ha celebrato sette anni dalla legalizzazione della cannabis in Canada, riaffermando la sua posizione come la più grande azienda canadese di cannabis legale per fatturato e mettendo in luce marchi leader e categorie di prodotto all'avanguardia. L'azienda cita >C$1 miliardo investiti nell'infrastruttura canadese, ~C$700 milioni pagati in tasse sugli accise, proprietà di 15 marchi leader (diversi valutati al dettaglio tra C$100M e C$300M), e la forza operativa del Q1FY26.

Tilray riporta 5 milioni di piedi quadrati di capacità di coltivazione, produzione attuale di 210 metriche tonnellate e una quota di mercato delle bevande >40% per XMG/Mollo.

Tilray Brands (Nasdaq: TLRY) celebró siete años desde la legalización del cannabis en Canadá, reiterando su posición como la mayor empresa de cannabis legal de Canadá por ingresos y destacando marcas y categorías de productos líderes en el mercado. La compañía cita >C$1 mil millones invertidos en infraestructura canadiense, ~C$700 millones pagados en impuestos especiales, la propiedad de 15 marcas líderes (varias valoradas en el comercio minorista entre C$100M y C$300M), y la fortaleza operativa del Q1FY26.

Tilray reporta 5 millones de pies cuadrados de capacidad de cultivo, una producción actual de 210 toneladas métricas, y una cuota de mercado de bebidas >40% para XMG/Mollo.

Tilray Brands (Nasdaq: TLRY)은 캐나다의 대마초 합법화로부터 7주년을 맞아 캐나다에서 매출 기준으로 가장 큰 합법 대마초 회사로 자리매김하고, 시장을 선도하는 브랜드와 제품 카테고리를 강조합니다. 회사는 캐나다 인프라에 >C$1십억 이상 투자했고, 소비세로 지불한 세금이 약 ~C$700백만이며, 15개의 주요 브랜드를 소유하고 있고(여러 소매가치가 C$100M~C$300M), Q1FY26의 운영 강점을 언급합니다.

Tilray는 5백만 제곱피트의 재배 용량, 현재 생산량 210 미터톤, 그리고 XMG/Mollo의 음료 시장 점유율이 >40%라는 정보를 제공합니다.

Tilray Brands (Nasdaq: TLRY) a marqué sept ans depuis la légalisation du cannabis au Canada, réaffirmant sa position de plus grande entreprise canadienne de cannabis légale par le chiffre d'affaires et mettant en évidence des marques et catégories de produits en tête du marché. La société cite >C$1 milliard canadiens investis dans les infrastructures canadiennes, ~C$700 millions payés en taxes d'accise, la détention de 15 marques leaders (plusieurs valorisées au détail entre C$100M et C$300M), et la solidité opérationnelle du Q1FY26.

Tilray indique une capacité de culture de 5 millions de pieds carrés, une production actuelle de 210 métriques tonnes, et une part de marché des boissons >40% pour XMG/Mollo.

Tilray Brands (Nasdaq: TLRY) feierte sieben Jahre seit der Legalisierung von Cannabis in Kanada, bekräftigte seine Position als größtes legales Cannabisunternehmen in Kanada nach Umsatz und hob marktführende Marken und Produktkategorien hervor. Das Unternehmen nennt >C$1 Milliarde investiert in kanadische Infrastruktur, ~C$700 Millionen an Verbrauchssteuern gezahlt, Eigentum an 15 führenden Marken (mehrere im Einzelhandel mit C$100M–C$300M bewertet), und operative Stärke im Q1FY26. Tilray berichtet eine Anbaukapazität von 5 Millionen Quadratfuß, aktuelle Produktion von 210 Metrik-Tonnen, und einen >40% Getränkekanalanteil für XMG/Mollo.

Tilray Brands (ناسداك: TLRY) احتفلت بمرور سبع سنوات على تقنين القنب في كندا، معيدة التأكيد على موقعها كأكبر شركة قنب قانونية في كندا من حيث الإيرادات وتسليط الضوء على العلامات التجارية والقطاعات الرائدة في السوق. تُشير الشركة إلى استثمار >1 مليار دولار كندي في البنية التحتية الكندية، و ~700 مليون دولار كندي مدفوعة كضرائب الجمرك/الاستهلاك، وامتلاكها 15 علامة تجارية رائدة (العديد منها مقيمة بقيمة التجزئة بين C$100M وC$300M)، والقوة التشغيلية في الربع الأول من السنة المالية 2026. Tilray تعلن عن سعة زراعة تبلغ 5 ملايين قدم مربع، وإنتاج حالي قدره 210 طنًا متريًا، ونسبة سوق المشروبات >40% لـ XMG/Mollo.

Tilray Brands (纳斯达克: TLRY) 自加拿大将大麻合法化以来已满七年,重申其为加拿大按收入计算最大的合法大麻公司的地位,并强调在市场中领先的品牌和产品类别。公司称在加拿大基础设施上投资超过10亿美元,已缴纳消费税约7亿美元,拥有15个领先品牌(若干在零售端估值在1亿美元至3亿美元之间),以及2026财年第一季度的运营实力。

Tilray 报告称拥有500万平方英尺的种植容量,当前产量为<210 公吨,XMG/Mollo 的饮料市场份额超过< b>40%。

Positive
  • Market leadership — largest legal cannabis company in Canada by revenue
  • C$1B+ invested in Canadian infrastructure
  • Approximately C$700M paid in excise taxes
  • 5M sq ft of advanced cultivation capacity
  • Current production of 210 metric tons
  • >40% Canadian THC beverage market share for XMG and Mollo
Negative
  • Existing regulatory restrictions in Canada cited as limiting competitiveness

Insights

Tilray presents materially positive operational and market-share facts in Canada, supporting a constructive near-term industry stance.

Tilray reports concrete scale and spending: over C$1 billion invested in Canadian infrastructure, approximately C$700 million in excise taxes paid, ownership of 15 leading brands with several retail valuations in the C$100 millionC$300 million range, and a reported production base of 210 metric tons across 5 million square feet of cultivation capacity. The company also claims #1 sales positions in several categories and sustained beverage leadership with > 40% share for XMG and Mollo, and it cites a strong operational quarter in Q1FY26.

These facts describe a large-scale, revenue-driving platform that depends on regulatory evolution and consumer channels to keep growing. Key dependencies named are reforms enabling Cannabis Health Products, broader insurance coverage, and on-premise THC beverage consumption; each could materially affect demand or distribution if adopted. Monitor regulatory milestones and formal policy decisions, upcoming quarterly disclosures following Q1FY26, and any published audited financials or category share reports over the next 6–18 months to verify sustained revenue leadership and the translation of scale into durable profitability.

TORONTO, Oct. 17, 2025 (GLOBE NEWSWIRE) -- Tilray Brands, Inc. ("Tilray" or the "Company") (Nasdaq: TLRY; TSX: TLRY), a global lifestyle and consumer packaged goods company at the forefront of the global cannabis, beverage, and wellness industries, proudly celebrates the seventh anniversary of cannabis legalization in Canada. As the largest federally legal cannabis market in the world, Canada’s progressive regulatory framework has fostered innovation and created vast economic opportunities for Canadian businesses and communities and set the global benchmark for responsible cannabis legalization and industry development.

Blair MacNeil, President of Tilray Canada, stated, “Seven years ago, Canada made history by becoming the first G7 country to legalize cannabis nationwide, a bold step that has set a global benchmark. I am deeply honoured that Tilray played a pivotal role in this transformative journey, championing responsible growth while supporting Canadian innovation and leadership. This milestone is a celebration of our dedicated team, our unwavering commitment to excellence, and, above all, the trust and support of Canadian consumers, who have made this industry a source of national pride.”

Following Canada’s legalization of cannabis on October 17, 2018, Tilray Brands’ licensed producers—including Aphria, Broken Coast, Hexo, Redecan, and a portfolio of other market-leading brands—have consistently led at the forefront of the country’s cannabis industry, setting benchmarks for quality, safety, scale, and innovation. Tilray’s economic footprint extends nationwide, generating thousands of jobs through its sales, marketing, cultivation, and manufacturing operations. The company has invested over C$1 billion in Canadian infrastructure, paid approximately C$700 million in excise taxes, and contributed hundreds of millions in harmonized, goods and services and provincial sales tax. These substantial investments have helped legitimize the cannabis industry, advancing the goal of eliminating the illicit market and ensuring patient and consumer safety by providing quality-controlled, rigorously tested products. Importantly, Tilray has also helped change people’s lives by providing safe, thoroughly tested medical cannabis to patients in need, supporting their health and well-being while expanding access to effective treatment options. Additionally, Tilray actively supports local economies through supplier partnerships, service contracts, charitable contributions, and sustainable business practices, reinforcing its commitment to responsible corporate citizenship, environmental stewardship, and community development.

Tilray’s brand-building excellence is evidenced by the 15 leading cannabis1 brands it owns and operates in Canada, with several brands valued at C$100 million – C$300 million each at retail2. By pioneering new product innovations, such as THC/CBD-infused beverages, shareable edibles, and premium craft flower, Tilray is expanding consumer choice and setting industry standards for quality. The Company is recognized for spearheading the adoption of greenhouse cannabis cultivation in Canada, leveraging advanced agronomic techniques to produce high-quality products at scale, while maintaining one of the industry’s lowest cost structures.

In Q1FY26, the most recent financial quarter reported, Tilray’s Canadian Cannabis business delivered strong results, reinforcing its position as Canada’s largest legal cannabis company by revenue. In the adult-use channel, Tilray continued to increase market share and achieved the strongest quarter over quarter growth among the top five Canadian cannabis producers. Tilray holds the #1 leading sales position in pre-rolls, beverages, oils, and chocolate edibles, and by the end of the quarter, we also became #1 in flower, while maintaining top 10 positions across all other categories3.

Tilray has maintained its lead in THC beverages, with its XMG and Mollo brands holding over 40% market share4 through innovative offerings like new flavours, zero-sugar options, and balanced THC/CBD seltzers. Edibles brand, Chowie Wowie, continues to set the standard in edibles with fun, consistent, and shareable chocolates, while Good Supply, Broken Coast, and Redecan remain consumer favourites for cannabis flower and pre-rolls.

While significant strides have been made, there is still important work to be done to further advance and refine regulations in Canada, ensuring the continued growth and success of the industry.

As regulatory reforms continue to evolve, we hope to see future growth driven by:

  • Expanding Cannabis in Healthcare – Unlocking new opportunities through proposed Cannabis Health Products and broader insurance coverage, making medical cannabis more accessible to patients.  
  • On-Premise Consumption of THC Beverages – Thoughtful rollout of on-site consumption to drive responsible use and create a vibrant, experiential cannabis beverage market.  
  • Regulatory Modernization – Improving policies that restrict competitiveness, paving the way for innovation and growth in Canada’s cannabis industry. 

Looking ahead, Tilray’s diversified platform is strategically positioned to capitalize on future industry growth, leveraging its unparalleled scale in Canada, with 5 million square feet of advanced cannabis cultivation facilities and current production of 210 metric tons, along with significant expansion capacity to swiftly respond to rising demand. This robust infrastructure ensures Tilray can adapt rapidly to evolving market dynamics and consumer preferences. Furthermore, as regulatory landscapes in Europe and the United States evolve, Tilray is exceptionally well equipped to seize new opportunities and establish a leading presence in these burgeoning markets, reinforcing its status as a global cannabis industry leader.

About Tilray Brands

Tilray Brands, Inc. (“Tilray”) (Nasdaq: TLRY; TSX: TLRY), is a leading global lifestyle and consumer packaged goods company with operations in Canada, the United States, Europe, Australia, and Latin America that is leading as a transformative force at the nexus of cannabis, beverage, wellness, and entertainment, elevating lives through moments of connection. Tilray’s mission is to be a leading premium lifestyle company with a house of brands and innovative products that inspire joy and create memorable experiences. Tilray’s unprecedented platform supports over 40 brands in over 20 countries, including comprehensive cannabis offerings, hemp-based foods, and craft beverages.

For more information on how we are elevating lives through moments of connection, visit Tilray.com and follow @Tilray on all social platforms.

Forward-Looking Statements

Certain statements in this communication that are not historical facts constitute forward-looking information or forward-looking statements (together, “forward-looking statements”) under Canadian and U.S. securities laws and within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, that are intended to be subject to the “safe harbor” created by those sections and other applicable laws. Forward-looking statements can be identified by words such as “forecast,” “future,” “should,” “could,” “enable,” “potential,” “contemplate,” “believe,” “anticipate,” “estimate,” “plan,” “expect,” “intend,” “may,” “project,” “will,” “would” and the negative of these terms or similar expressions, although not all forward-looking statements contain these identifying words. Certain material factors, estimates, goals, projections, or assumptions were used in drawing the conclusions contained in the forward-looking statements throughout this communication. Forward-looking statements include statements regarding our intentions, beliefs, projections, outlook, analyses, or current expectations. Many factors could cause actual results, performance, or achievement to be materially different from any forward-looking statements, and other risks and uncertainties not presently known to the Company or that the Company deems immaterial could also cause actual results or events to differ materially from those expressed in the forward-looking statements contained herein. For a more detailed discussion of these risks and other factors, see the most recently filed annual information form of Tilray and the Annual Report on Form 10-K (and other periodic reports filed with the SEC) of Tilray made with the SEC and available on EDGAR. The forward-looking statements included in this communication are made as of the date of this communication and the Company does not undertake any obligation to publicly update such forward-looking statements to reflect new information, subsequent events, or otherwise unless required by applicable securities laws.

For further information, please contact

Media: news@tilray.com
Investors: investors@tilray.com


1 Source: Hifyre Data, National, September 2025
2 Source: Hifyre Data, National, Oct 1, 2024 - Sept 30, 2025
3 Source: Hifyre Data, National, Oct 1, 2024 - Sept 30, 2025
4 Source: Hifyre Data, National, Oct 1, 2024 - Sept 30, 2025


FAQ

What did Tilray (TLRY) announce on October 17, 2025 about its Canada position?

Tilray said it is Canada's largest legal cannabis company by revenue and highlighted brand, capacity, and market-share metrics.

How much has Tilray (TLRY) invested in Canadian infrastructure as of Oct 17, 2025?

Tilray reported investing over C$1 billion in Canadian infrastructure.

What production capacity did Tilray (TLRY) report in Q1FY26?

Tilray reported 5 million sq ft of cultivation facilities and current production of 210 metric tons.

What market share do XMG and Mollo hold for THC beverages according to Tilray (TLRY)?

Tilray reported its XMG and Mollo brands hold over 40% market share in Canadian THC beverages.

How much excise tax has Tilray (TLRY) paid in Canada?

Tilray stated it has paid approximately C$700 million in excise taxes.

Does Tilray (TLRY) see regulatory headwinds in Canada after seven years of legalization?

Yes; the company noted regulatory modernization is needed to improve competitiveness and support future growth.
TILRAY BRANDS INC

NASDAQ:TLRY

TLRY Rankings

TLRY Latest News

TLRY Latest SEC Filings

TLRY Stock Data

1.73B
1.11B
0.82%
10.04%
14.74%
Drug Manufacturers - Specialty & Generic
Medicinal Chemicals & Botanical Products
Link
Canada
NEW YORK